title: Treatment of Refractory Pityriasis Rubra Pilaris With Novel Phosphodiesterase 4 (PDE4) Inhibitor Apremilast.
authors.affiliation: University of Arizona College of Medicine, Tucson.
authors.forename: Ifat Zerin
authors.initials: IZ
authors.lastname: Krase
authors.affiliation: Department of Dermatology, University of Arizona, Tucson.
authors.forename: Kevin
authors.initials: K
authors.lastname: Cavanaugh
authors.affiliation: Department of Dermatology, University of Arizona, Tucson.
authors.forename: Clara
authors.initials: C
authors.lastname: Curiel-Lewandrowski
mesh_terms: D000368:Aged; D001706:Biopsy; D004351:Drug Resistance; D057915:Drug Substitution; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D058988:Phosphodiesterase 4 Inhibitors / Q000627:therapeutic use*; D010916:Pityriasis Rubra Pilaris / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D012074:Remission Induction; D012867:Skin / Q000187:drug effects / Q000473:pathology; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D058988:Phosphodiesterase 4 Inhibitors; D013792:Thalidomide; C505730:apremilast